World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01454609
Date of registration: 08/10/2011
Primary sponsor: Jawaharlal Institute of Postgraduate Medical Education & Research
Public title: Safety and Efficacy of Bilateral Superficial Cervical Plexus Block in Thyroidectomy
Scientific title: Safety and Efficacy of Bilateral Superficial Cervical Plexus Block in Thyroidectomy - a Double Blind Randomized Controlled Trial
Date of first enrolment: January 2009
Target sample size: 60
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01454609
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment  
Countries of recruitment
India
Contacts
Name:   Sarath Chandra Sistla, MS(Surgery)
Address: 
Telephone:
Email:
Affiliation:  Professor, Dept. of Surgery, JIPMER
Key inclusion & exclusion criteria

Inclusion Criteria:

- Consenting consecutive euthyroid patients undergoing elective thyroidectomy under
general anesthesia, of either genders and more than 18 years of age, belonging to the
ASA class I and II.

Exclusion Criteria:

- Patients unable to understand visual analog pain score (VAS) or unable to use patient
controlled analgesia (PCA).

- Patients with malignancy requiring block dissection or with substernal goiters -
Contraindications to superficial cervical plexus block like allergy to local
anesthetics, bleeding diatheses and local infection or sepsis.

- Contraindications to morphine like bronchial asthma and hypothyroidism.

- Sensitivity to the anesthetic agent used or intolerance to the medications used in
the study.

- Patients who received steroids or opioids or other analgesics recently.

- Patients with history of stridor.



Age minimum: 20 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Pain
Postoperative
Intervention(s)
Device: Bupivacaine with clonidine (combination)
Drug: 0.9% Normal saline
Drug: Bupivacaine
Primary Outcome(s)
Intraoperative fentanyl requirement and the total morphine requirements in the 24-hour postoperative period [Time Frame: Intraoperative to 24 hours postoperative]
Secondary Outcome(s)
Postoperative nausea and vomiting (PONV)and anti emetic requirements [Time Frame: 24 hours postoperative]
Side effects of the block, morphine and clonidine [Time Frame: 24 hours postoperative]
Visual analog pain scores at specific time intervals [Time Frame: 24 hours postoperative]
Secondary ID(s)
100745483-1910201028464726
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history